Android Apple
  • Home
  • Stock Market News
  • Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages

Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages

By Yahoo! Finance   |   2 months ago
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages

The FDA resolved the shortage of Eli Lilly's tirzepatide injection, a GLP-1 medication. Compounders reminded of legal restrictions on making copies of FDA-approved drugs. Hims & Hers Health expects strong demand for compounded weight loss service post-supply shortages.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.